This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Perry, G. Articles by Kawai, M. Search for Related Content PubMed PubMed Citation Articles by Perry, G. Articles by Kawai, M.

American Journal of Pathology, Vol 140, 283-290, Copyright © 1992 by American Society for Investigative Pathology

REGULAR ARTICLES

Beta protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease

G Perry, P Cras, SL Siedlak, M Tabaton and M Kawai
Division of Neuropathology, Case Western Reserve University, Cleveland, Ohio 44106-4901.

The presence of dystrophic neurites in most extracellular neurofibrillary tangles (E-NFT) suggests a factor promoting neurite growth in E-NFT. Although the beta-protein detected in E-NFT may fill that role, reports that only 2-10% of E-NFT contain beta-protein whereas 80-100% contain dystrophic neurites suggested that beta-protein does not play an important role. In this study, the authors used two antisera and one monoclonal antibody to beta-protein to establish the effects of tissue preparation and formic acid enhancement on the detection of beta-protein in E-NFT. We found that beta-protein epitopes in E-NFT are sensitive to formaldehyde fixation and are best enhanced by 50% formic acid, whereas beta-protein in senile plaques is best enhanced at higher formic acid concentrations. After treatment with 50% formic acid, beta-protein was found in all E-NFT. Interestingly, after treatment with 10% formic acid, half of intraneuronal-NFT (I-NFT) also contained beta-protein immunoreactivity. The finding that beta-protein immunoreactivity in senile plaques, E-NFT and I-NFT is increased at different formic acid concentrations suggests that beta-protein in each location is in a different conformation. In contrast, no beta-protein immunoreactivity could be found in E-NFT of the brain stem, an area in which dystrophic neurites do not infiltrate E-NFT. These findings indicate a correlation between neuritic infiltration and presence of beta-protein in E-NFT and suggests the two are linked in Alzheimer's disease for E-NFT as well as senile plaques.

This article has been cited by other articles:

				L. Gregori, J. F. Hainfeld, M. N. Simon, and D. Goldgaber Binding of Amyloid beta Protein to the 20S Proteasome J. Biol. Chem., January 3, 1997; 272(1): 58 - 62. [Abstract] [Full Text] [PDF]

				R. Wang, D. Sweeney, S. E. Gandy, and S. S. Sisodia The Profile of Soluble Amyloid beta Protein in Cultured Cell Media. DETECTION AND QUANTIFICATION OF AMYLOID beta PROTEIN AND VARIANTS BY IMMUNOPRECIPITATION-MASS SPECTROMETRY J. Biol. Chem., December 13, 1996; 271(50): 31894 - 31902. [Abstract] [Full Text] [PDF]